Texas Tech University

COVID-19 Guidelines for Researchers

The Office of Research and Innovation continues to work with the campus leadership and community to establish guidance specific to research operations. The following information is intended to assist the campus research community in limiting the impact and potential risk associated with COVID-19. Please check back for updates or contact OR&I with any questions at research.innovation@ttu.edu.

For more information on the university's updates, please visit the Texas Tech University COVID-19 page. For more information on academic resources, please visit the Office of the Provost's page. 

Last update: Augst 11, 2021

Reporting a Documented Case of COVID-19

All notifications should be reported to hr.talent.management@ttu.edu.

COVID-19 Awareness Training

 

Agency Updates

Click each agency for a full list of updates. 

✔ Agency temporarily adjusted terms and conditions
X Agency has not temporarily adjusted standard terms and conditions or has not issued updated guidance
✔X Agency has adjusted some but not all conditions

Agency Possible deadline flexibility Waiver for Notice of Funding Opportunities (NOFOs) Publication No-cost extensions on expiring awards Abbreviated continuation requests Allowability of salaries and other project activities Allowability of costs not normally chargeable to awards (ex: non-refundable travel costs) Prior approval requirement waivers Exemption of certain procurement requirement Extension of financial and other reporting Extension of closeout Pre-award Costs
 NSF  N/A  X ✔  ✔  ✔ X  
NIH            ✔ X   
 DOD - BR/RD            ✔  
 DOD-AFOSR      ✔                
 DOE  ✔X  ✔X ✔X  ✔X  ✔X   ✔X  
 DHHS  ✔    ✔X  ✔X ✔X   ✔  ✔X  
 FDA         ✔X     ✔X    
 NASA  ✔  ✔X  ✔X  ✔X ✔X   X  
USDA -NIFA   ✔X  ✔X  X ✔X   √  
 NEH ✔X    ✔X  ✔      √  √  
Welch                  

 

Funding Opportunities Related to COVID-19

American Heart Association

Biomedical Advanced Research & Development Authority

Centers for Disease Control

  • Centers for Disease Control COVID-19 Broad Agency Announcement
    THIS IS AN IMMEDIATE CALL FOR WHITE PAPERS. Prior to submission of a white paper, offerors are strongly encouraged to contact the CDC BAA technical point of contact for the research topic/subtopic of interest. White papers must be received electronically by 3:00PM EST on March 25, 2020 in order to be considered for further evaluation.

Department of Defense

Department of Energy

National Institute for Health Research

  • Travel and Subsistence Funding to Support LMIC Engagement During the COVID-19 Outbreak
    This scheme provides travel and subsistence funding to support delivery of technical expertise in the global response to Covid-19. This service is not delivered to, or on behalf of, the Department of Health and Social Care (DHSC)/the National Institute for Health Research (NIHR) and does not constitute a contractual or service agreement, employer/employee or agent/principal relationship between any institution, body or person and the DHSC/NIHR.

National Institute of Allergy and Infectious Diseases

  • Notice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) (NOT-AI-20-030) (February 6, 2020)
    The National Institute of Allergy and Infectious Diseases and the National Institute of General Medical Sciences are issuing this NOSI to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV. NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens.
  • 2020 NIAID Omnibus Broad Agency Announcement
    NIAID 2020 OMNIBUS BROAD AGENCY ANNOUNCEMENT (BAA) NO. HHS-NIH-NIAID-BAA2020-1 contains five (5) distinct Research Areas, each with a specified closing date and time.

National Institutes of Health

National Science Foundation

  • Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
    This Dear Colleague Letter (DCL) complements a separate National Science Foundation (NSF) DCL (NSF 20-052) that referred to the emergence of the coronavirus disease 2019 (COVID-19) and expressed NSF's interest in accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to better understand how to model and understand the spread of COVID-19; to inform and educate about the science of virus transmission and prevention; and to encourage the development of processes and actions to address this global challenge.
  • Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)
    Before submitting a RAPID proposal or supplemental funding request in response to this DCL, investigators must first contact one of the cognizant OAC program officers listed.
    Through this DCL, the Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities. Such activities would be funded by the Computational and Data-Enabled Science and Engineering (CDS&E) program or the Cyberinfrastructure for Sustained Scientific Innovation (CSSI) program.
  • DCL: Request for SBIR/STTR Phase I Proposals Addressing COVID-19
    The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation's and world's ability to respond to the COVID-19 crisis. Areas of research that might be considered include, but are not limited to: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. Interested proposers are invited to submit to the NSF Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I Program.

United States Department of Agriculture

Rapid Response to Novel Coronavirus (SARS-CoV-2) Impacts Across Food and Agricultural Systems

Other funding and research resources

Elsevier

  • Novel Coronavirus Information Center
    Elsevier's free health and medical research on the novel coronavirus (SARS-CoV-2) and COVID-19
  • Elsevier COVID-19 Clinical Toolkit
    Open access to clinical resources and tools focused on the latest evidence-based practices for COVID-19 covering topics from symptom management to diagnosis, treatment and ongoing wellness.
  • Infectious Disease Outbreak Research: Insights and Trends (on demand webinar)
    Please join us for this webinar as Dr. Bamini Jayabalasingham explains how the research was conducted to uncover trends in outbreaks research, the various governmental bodies involved and the ways to identify health security research. Dr. Margaret Trexler Hessen will provide insight into how the research fits into the clinical context and why it matters. ​